Pfizer Inc Pyxis Oncology, Inc. (PYXS) insider trading activity

PYXS Quotes by TradingView

Pfizer Inc is > 10% Shareholder of Pyxis Oncology, Inc.. Currently has a direct ownership of 5.95 Million shares of PYXS, which is worth approximately $11.8 Million. The most recent transaction as insider was on Mar 17, 2023, when has been sold 1,811,594 shares (Common Stock, $0.001 par value per share) at a price of $2.76 per share, resulting in proceeds of $4,999,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.95M
0% 3M change
0% 12M change
Total Value Held $11.8 Million

PFIZER INC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 17 2023
BUY
Open market or private purchase
$4,999,999 $2.76 p/Share
1,811,594 Added 23.33%
5,952,263 Common Stock, $0.001 p...

Also insider at

VTRS
Viatris Inc Healthcare
> 10% Shareholder
CERE
Cerevel Therapeutics Holdings, Inc. Healthcare
ICUI
ICU MEDICAL INC Healthcare
Director
ALLO
Allogene Therapeutics, Inc. Healthcare
> 10% Shareholder
SWTX
SpringWorks Therapeutics, Inc. Healthcare
> 10% Shareholder
BCAB
BioAtla, Inc. Healthcare
> 10% Shareholder
CRTX
Cortexyme, Inc. Healthcare
> 10% Shareholder
IMRA
IMARA Inc. Healthcare
> 10% Shareholder
PI

Pfizer Inc

> 10% Shareholder
New York, NY

Track Institutional and Insider Activities on PYXS

Follow Pyxis Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PYXS shares.

Notify only if

Insider Trading

Get notified when an Pyxis Oncology, Inc. insider buys or sells PYXS shares.

Notify only if

News

Receive news related to Pyxis Oncology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PYXS